Advanced search
Start date
Betweenand


Effects of TSPO ligands on leukocyte migration: role of glucocorticoids receptors

Full text
Author(s):
Camila Bento de Lima
Total Authors: 1
Document type: Doctoral Thesis
Press: São Paulo.
Institution: Universidade de São Paulo (USP). Conjunto das Químicas (IQ e FCF) (CQ/DBDCQ)
Defense date:
Examining board members:
Sandra Helena Poliselli Farsky; Ana Campa; Wothan Tavares de Lima; Paulina Sannomiya; Eduardo Koji Tamura
Advisor: Sandra Helena Poliselli Farsky
Abstract

Besides central benzodiazepine receptor (CBR) found on central nervous system (CNS) coupled to GABAA, another binding site for benzodiazepines was described and named peripheral benzodiazepine receptor (PBR) or Translocator protein (TSPO). The mainly function described to this TSPO is steroidogenesis. Additionally, its function as an immune modulator has been proposed with the involvement, at least in part, of endogenous glucocorticoids (EG). However, mechanisms of TSPO modulation on inflammatory process and the relation between the receptor and EG has not been totally established. This study aimed investigates effects of two synthetic TSPO ligands, a benzodiazepine, Ro5-4864, and an isoquinoline carboxamide, PK 11195, and their relation with EG on leukocyte migration. For this purpose, male Wistar rats were in vivo treated with RU 38486 (EG antagonist receptor) or vehicle and, in addition, TSPO ligands, Ro5-4864 and/or PK 11195, were topically applied on animal mesentery microcirculation to evaluate leukocyte rolling and adhesion, by intravital microscopy, under basal conditions or after stimulation by N-formyl-methionine-leucine-phenylalanine (fMLP). In addition, peripheral leukocytes were collected and in vitro treated with TSPO ligands to evaluate adhesion molecules expression, chemotaxis and calcium influx. Endothelial cells obtained from cremaster muscle were in vitro treated with TSPO ligands to evaluate adhesion molecules expression under basal conditions or after stimulation by lipopolysaccharide from E.coli (LPS). Our results showed that: 1) TSPO ligand, Ro5-4864, altered the fMLP action since TSPO ligand inhibited the decrease of rolling, the increase of adherent cells, L-selectin cleavage, the increase of PECAM-1 expression, neutrophil chemotaxis and calcium influx; did not affect expression of PECAM-1 and ICAM-1 induced by LPS on endothelial cells; 2) PK 11195 increased fMLP-induced neutrophil calcium influx and chemotaxis; 3) co-administration of TSPO ligands, Ro5-4864 and PK 11195, reverted Ro5-4864 effects on L-selectin and PECAM-1 expression, neutrophil and calcium influx, as well as PECAM-1 and ICAM-1 expression on endothelial cells; 3) a possible inter-relation between TSPO and EG was observed since Ro5-4864 inhibited the increase of in vivo leukocyte rolling and adhesion induced by RU 38486 in vivo treatment; it inhibited the increase of neutrophil L-selectin, lymphocyte β2-integrin and leukocyte PECAM-1 expressions; 4) It was showed that neutrophil have more TSPO than lymphocytes and endothelial cells, and this expression is increased by fMLP stimulation. Taken together, our results suggest that TSPO ligands differently modulate leukocyte adhesion and motility functions and endothelial cells adhesion, and further, they suggest an allosteric agonist/antagonist relation. Additionally, they showed a relation between TSPO and EG cytoplasmic receptor on the control of leukocyte-endothelial interaction. (AU)